Literature DB >> 7922521

Adenoviral vectors as functional retrograde neuronal tracers.

V Ridoux1, J J Robert, X Zhang, M Perricaudet, J Mallet, G Le Gal La Salle.   

Abstract

Adenoviruses have been recently recognized as a highly efficient system for gene delivery to various tissues. The ability of replication-defective recombinant adenovirus to transfer the lacZ reporter gene encoding beta-galactosidase to nerve cells in various brain structures has been demonstrated. Here, on the continuation of these studies, we present evidence that the adenovirus can be transported in a retrograde manner to nerve cell bodies from axonal terminals. This method may be of great value for infecting selected subsets of specific neurons for either anatomo-functional studies or even therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7922521     DOI: 10.1016/0006-8993(94)91919-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

2.  Cytoplasmic dynein mediates adenovirus binding to microtubules.

Authors:  Samir A Kelkar; K Kevin Pfister; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Authors:  Franck Lemiale; Wing-pui Kong; Levent M Akyürek; Xu Ling; Yue Huang; Bimal K Chakrabarti; Michael Eckhaus; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.

Authors:  Y Wang; L A Krushel; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 5.  Gene therapy for Parkinson's disease.

Authors:  P Horellou; J Mallet
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

6.  Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain.

Authors:  M C Senut; S T Suhr; B Kaspar; F H Gage
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

7.  Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.

Authors:  A Ly; H T Duc; M Kalamarides; L A Trojan; Y Pan; A Shevelev; J C François; T Noël; A Kane; D Henin; D D Anthony; J Trojan
Journal:  Mol Pathol       Date:  2001-08

8.  Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination.

Authors:  A P Byrnes; R E MacLaren; H M Charlton
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

9.  Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration.

Authors:  A Hurtado-Lorenzo; E Millan; V Gonzalez-Nicolini; D Suwelack; M G Castro; P R Lowenstein
Journal:  Mol Ther       Date:  2004-09       Impact factor: 11.454

10.  Retrograde adenoviral vector targeting of nociresponsive pontospinal noradrenergic neurons in the rat in vivo.

Authors:  Patrick W Howorth; Anja G Teschemacher; Anthony E Pickering
Journal:  J Comp Neurol       Date:  2009-01-10       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.